A detailed history of Nalls Sherbakoff Group, LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 15 shares of CMPS stock, worth $128. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 30 50.0%
Holding current value
$128
Previous $222,000 40.54%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024

SELL
N/A
-15 Reduced 50.0%
15 $132,000
Q1 2023

Oct 17, 2023

BUY
$7.32 - $10.85 $219 - $325
30 New
30 $312,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Nalls Sherbakoff Group, LLC Portfolio

Follow Nalls Sherbakoff Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nalls Sherbakoff Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nalls Sherbakoff Group, LLC with notifications on news.